Join a Clinical Trial: Earn Money While Helping to Combat Malaria

A clinical trial is underway to explore a groundbreaking malaria vaccine. Researchers seek 22 healthy participants aged 18 to 45 for this vital study, which investigates the PfSPZ-LARC2 vaccine, fashioned by Sanaria. This experimental vaccine employs a weakened malaria parasite to potentially enhance protective responses. Participants will receive either the vaccine or a placebo and undergo controlled malaria exposure, allowing researchers to assess its efficacy. Commitment involves up to 38 clinic visits over the year, with compensation provided. Dr. Scott McClelland emphasizes the trial's importance in combating malaria.